Loihde’s Q2 was better than anticipated. Net sales grew a modest 3% to EUR 35.
PMD Device Solutions (“PMD”) has consolidated the US acquisition and a combination of cost control a...
Sales +2%, but EBITA -24% vs. ABGSCe, driven by personnel costs Slower cost reductions than we had t...
Redeye concludes that Q2 revenues were weaker than expected, derived from short-term delays and orde...
5% org. sales growth, 7% adj. EBITA growth, neg. cash flow '24e-'26e adj.
Redeye updates its view of Curasight following the Q2 report and recent events in the company, inclu...
Embark Group (f.d. Lucky Games) har publicerat bolagets delårsrapport för det andra kvartalet år 202...
Q2: sales SEK 43m +30% y-o-y, adj. EBIT margin 28% (23%) Raise both '24e-'26e sales and EBIT by 7-5%...
Mangold uppdaterar cybersäkerhetsbolaget Cyber Security 1 (”CYBER1”).
While the commercialization of Crunchfish’s solution for offline payments has shown a longer sales c...
Redeye is encouraged by the recent commercial progress, particularly in the Chinese market.
Redeye provides a research update following the Q2 2024 report from Kancera.
InfraCom’s report was weak, and the company faces a cocktail of headwinds.
Redeye makes upward estimate revisions on the back of I-Tech’s solid Q2 figures.
Redeye sees a Q2 report roughly matching our expectations.
Q2 sales were in line, EBITDA 11% better Continues to scale well; sales +17%, opex +3% y-o-y Trading...
AcuCort (”AcuCort” eller ”Bolaget”) har publicerat Bolagets delårsrapport för det andra kvartalet 20...
Luxbright AB (”Luxbright” eller ”Bolaget”) har publicerat Bolagets delårsrapport för det första halv...
Redeye provides its comment on Mendus’ Q2 2024 report.
Kinda Brave Entertainment Group AB (”Kinda Brave” eller ”Koncernen”) har publicerat Koncernens delår...
